CASP3 and glioblastoma: Evaluation of harvested flank tumors by immunohistochemistry (IHC) staining revealed robust cleaved caspase 3 tissue expression in response to Xevinapant treatment, indicating that there was significant activation of apoptosis in GBM xenografts, compared to the control group (Fig. S3C).